Skip to main content

Advertisement

Table 3 Analysis of clinical characteristics in NCAN (rs2228603 C/T) carriers and non-carriers of the study populationa

From: Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study

Characteristic Overall series NAFLD patients Controls
Carriers Non-carriers P Carriers Non-carriers P Carriers Non-carriers P
Age, y 44.74 ± 11.20 42.91 ± 12.01 0.234 48.58 ± 10.69 45.54 ± 11.74 0.174 41.66 ± 10.74 40.36 ± 11.75 0.524
Female/male 45/29 200/103 0.401 14/19 83/66 0.166 31/10 117/37 0.961
Height, cm 167.35 ± 7.76 166.43 ± 8.89 0.416 168.45 ± 8.20 166.89 ± 11.00 0.441 166.46 ± 7.36 166.00 ± 6.22 0.682
Weight, Kg 68.41 ± 11.77 68.70 ± 12.67 0.857 71.39 ± 10.34 74.91 ± 11.61 0.110 66.00 ± 12.41 62.69 ± 10.60 0.123
ALT, U/L 22.43 ± 12.41 22.60 ± 12.99 0.920 24.55 ± 12.09 25.87 ± 14.90 0.633 20.73 ± 12.55 19.44 ± 9.90 0.483
AST, U/L 20.68 ± 8.04 20.75 ± 9.40 0.953 20.45 ± 5.84 22.22 ± 12.09 0.415 20.85 ± 9.52 19.32 ± 5.36 0.177
GGT, U/L 17.77 ± 7.631 18.56 ± 8.872 0.479 20.67 ± 8.855 22.52 ± 9.776 0.317 15.44 ± 5.572 14.73 ± 5.735 0.482
TBIL, umol/L 13.43 ± 5.41 13.70 ± 5.97 0.725 12.28 ± 4.94 14.32 ± 6.64 0.097 14.36 ± 5.64 13.09 ± 5.19 0.174
AKP, U/L 65.18 ± 13.75 64.73 ± 17.22 0.017 69.94 ± 16.51 69.34 ± 18.60 0.070 67.95 ± 10.75 60.28 ± 14.50 0.258
Glu. mmol/L 5.04 ± 0.86 5.31 ± 1.66 0.182 5.21 ± 1.09 5.66 ± 1.90 0.194 4.91 ± 0.60 4.98 ± 1.32 0.756
UA, umol/L 307.59 ± 81.35 337.55 ± 156.11 0.111 335.42 ± 98.44 370.85 ± 201.84 0.328 285.20 ± 56.33 305.33 ± 81.03 0.136
TG, mmol/L 1.46 ± 1.28 1.65 ± 1.81 0.381 2.00 ± 1.67 1.98 ± 1.81 0.964 1.03 ± 0.57 1.34 ± 1.75 0.263
TC, mmol/L 4.80 ± 0.92 4.77 ± 0.96 0.825 4.88 ± 0.83 4.93 ± 0.98 0.799 4.73 ± 0.98 4.62 ± 0.92 0.493
HDL, mmol/L 1.47 ± 0.25 1.37 ± 0.44 0.009 1.31 ± 0.26 1.29 ± 0.50 0.861 1.60 ± 0.14 1.44 ± 0.36 0.000
LDL, mmol/L 3.04 ± 0.85 3.13 ± 0.89 0.452 3.18 ± 0.68 3.33 ± 0.98 0.403 2.94 ± 0.96 2.94 ± 0.76 0.985
  1. Abbreviations: ALT Alanine aminotransferase, AST Aspartate aminotransferase, GGT gamma-glutamyltranspeptidase, TBIL Total bilirubin, AKP alkaline phosphatase, GLU glucose, UA Uric acid, TG Triglyceride, TC Total cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. aData are presented as Mean ± SD